Nivalis Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 36% in the past one-month time frame.

The company has seen one negative revision in the past one month, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Nivalis Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is positive.

NIVALIS THERAPT Price

 

NIVALIS THERAPT Price | NIVALIS THERAPT Quote

A better-ranked stock in the same industry is Corcept Therapeutics Incorporated (CORT Quick QuoteCORT - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is NVLS going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>